Issue: November 2012
November 01, 2012
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
CANVAS
Issue: November 2012
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Substudy of CANVAS evaluated the efficacy and tolerability of canagliflozin in insulin users with diabetes at elevated risk for CVD.